Empress Medical

Fibroid Treatment and Fertility Solutions

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo Founded 2019
Total raised
Last: Undisclosed 2019-05
Stage
Seed
Founded
2019
Headcount
5
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Empress Medical is developing fibroid treatment solutions.

The company is focused on changing the standard of care for women worldwide and reducing the number of hysterectomies by introducing an easy-to-use laparoscopic technology designed for gynecologists operating in average settings, making it accessible to more underserved women, delivering on the promise to offer a broader base of women a safe, uterus-preserving fibroid treatment option, and preserving fertility.

The Empress system is intended to treat symptomatic uterine fibroids in a laparoscopic procedure by inducing fibroid tissue ischemia. Sutures wrapped around the fibroid increase the intra-tumoral pressure, which leads to fibroid ischemia — blockage of intra- and peri-fibroid blood flow — and, eventually, necrosis of the fibroid tissue.

Funding history · 1 round · — total

2019-05
Undisclosed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

laparoscopyminimally-invasivemedical-devicesfertilityfemtech